Invention Grant
- Patent Title: Pyrrolidine derived beta 3 adrenergic receptor agonists
- Patent Title (中): 吡咯烷衍生的β3肾上腺素能受体激动剂
-
Application No.: US13392282Application Date: 2010-08-24
-
Publication No.: US08604038B2Publication Date: 2013-12-10
- Inventor: Scott D. Edmondson , Lehua Chang , Nam Fung Kar , Gergori J. Morriello , Christopher R. Moyes , Dong-Ming Shen , Cheng Zhu , Neville J. Anthony , Philip Jones , Graham F. Smith , Mark E. Scott , Christopher F. Thompson , Joon Jung , Carolyn Cammarano , Dawn Marie Hoffman
- Applicant: Scott D. Edmondson , Lehua Chang , Nam Fung Kar , Gergori J. Morriello , Christopher R. Moyes , Dong-Ming Shen , Cheng Zhu , Neville J. Anthony , Philip Jones , Graham F. Smith , Mark E. Scott , Christopher F. Thompson , Joon Jung , Carolyn Cammarano , Dawn Marie Hoffman
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Patricia A. Shatynski; Valerie J. Camara
- International Application: PCT/US2010/046468 WO 20100824
- International Announcement: WO2011/025774 WO 20110303
- Main IPC: A61K31/50
- IPC: A61K31/50 ; A61K31/525
Abstract:
The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
Public/Granted literature
- US20120225886A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS Public/Granted day:2012-09-06
Information query
